Search

Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials. Ivabradine and empagliflozin Ivabradine and spironolactone Spironolactone and empagliflozin Empagliflozin only B Part II: Oral anticoagulants in patients with antiphospholipid syndrome. b You are evaluating a patient with a history of arterial thrombus for a potential diagnosis of antiphospholipid syndrome (APS). Effect of 1-month dual antiplatelet therapy followed by clopidogrel vs 12-month dual antiplatelet therapy on cardiovascular and bleeding events in patients receiving PCI: the STOPDAPT-2 randomized clinical trial. Catastrophic APS Obstetric APS Primary APS Secondary APS A 38-year-old man with secondary APS presents with recurrent arterial thrombotic event while on adequate warfarin therapy. [Extracted from the article]